Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

Holch, JW; Ricard, I; Stintzing, S; von Weikersthal, LF; Decker, T; Kiani, A; Vehling-Kaiser, U; Heintges, T; Kahl, C; Kullmann, F; Scheithauer, W; Moehler, M; Jelas, I; Modest, DP; Westphalen, CB; von Einem, JC; Michl, M; Heinemann, V

Holch, JW (reprint author), Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Comprehens Canc Ctr Munich, Dept Internal Med 3, Marchioninistr 15, D-81377 Munich, Germany.

EUROPEAN JOURNAL OF CANCER, 2019; 106 (): 115

Abstract

Purpose: Increased baseline carcinoembryonic antigen (CEA) serum level is associated with inferior overall survival (OS) in metastatic colorectal canc......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索